EP3796934 - BISPECIFIC T CELL ENGAGER AND USES THEREOF [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 26.02.2021 Database last updated on 09.09.2024 | |
Former | The international publication has been made Status updated on 30.11.2019 | Most recent event Tooltip | 01.06.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states MANYSMART THERAPEUTICS, INC. No. 236, Minzu W. Road Datong Dist. Taipei City 10375 / TW | [2021/13] | Inventor(s) | 01 /
HUANG, Hsin-Yi 4f., No. 236, Minzu W. Rd. Datong Dist. Taipei City, 10375 / TW | 02 /
LIAO, Cheng Hao 4f., No. 236, Minzu W. Rd. Datong Dist. Taipei City, 10375 / TW | [2021/13] | Representative(s) | 2K Patentanwälte Blasberg Kewitz & Reichel Partnerschaft mbB Schumannstrasse 27 60325 Frankfurt am Main / DE | [2021/13] | Application number, filing date | 19806758.9 | 23.05.2019 | [2021/13] | WO2019US33752 | Priority number, date | US201862675208P | 23.05.2018 Original published format: US 201862675208 P | [2021/13] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019226894 | Date: | 28.11.2019 | Language: | EN | [2019/48] | Type: | A1 Application with search report | No.: | EP3796934 | Date: | 31.03.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 28.11.2019 takes the place of the publication of the European patent application. | [2021/13] | Search report(s) | International search report - published on: | US | 28.11.2019 | (Supplementary) European search report - dispatched on: | EP | 09.03.2022 | Classification | IPC: | A61K39/395, C07K16/28, C07K19/00, C12N1/15, C12N1/21, C12N5/10, C12N15/63, C12P21/02, A61K39/44, A61P31/22, A61P35/00, C07K14/735, C07K16/08, C07K16/32 | [2022/14] | CPC: |
C07K14/70535 (EP,KR,US);
C07K16/2809 (EP,KR,US);
A61K38/00 (KR);
A61K39/44 (EP);
A61P31/22 (EP,US);
A61P35/00 (EP,KR,US);
A61P35/02 (EP);
A61P37/06 (KR);
C07K16/085 (EP);
C07K16/2827 (EP);
C07K16/283 (EP);
C07K16/2863 (EP);
C07K16/2887 (EP);
C07K16/32 (EP);
C12N15/62 (EP);
A61K2039/505 (EP,US);
A61K2039/507 (EP);
A61K2039/5256 (EP);
A61K2039/585 (EP);
C07K2317/24 (EP);
C07K2317/622 (EP,KR,US);
C07K2317/73 (EP);
C07K2317/732 (KR,US);
C07K2319/00 (KR);
C07K2319/02 (EP,KR,US);
C07K2319/21 (EP,KR);
C07K2319/32 (EP);
|
Former IPC [2021/13] | A61K39/395, C07K16/28, C07K19/00, C12N1/15, C12N1/21, C12N5/10, C12N15/63, C12P21/02 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/13] | Title | German: | BISPEZIFISCHER T-ZELL-ENGAGER UND VERWENDUNGEN DAVON | [2021/13] | English: | BISPECIFIC T CELL ENGAGER AND USES THEREOF | [2021/13] | French: | ACTIVATEUR DE LYMPHOCYTES T BISPÉCIFIQUE ET SES UTILISATIONS | [2021/13] | Entry into regional phase | 03.12.2020 | National basic fee paid | 03.02.2021 | Search fee paid | 03.12.2020 | Designation fee(s) paid | 03.12.2020 | Examination fee paid | Examination procedure | deleted | Deletion: Application deemed to be withdrawn, date of legal effect [2021/13] | 03.12.2020 | Examination requested [2021/13] | 02.02.2021 | Despatch of communication that the application is deemed to be withdrawn, reason: filing fee / search fee not paid in time [2021/13] | 21.09.2022 | Amendment by applicant (claims and/or description) | Request for further processing for: | The application is deemed to be withdrawn due to non-payment of the search fee | 03.02.2021 | Request for further processing filed | 03.02.2021 | Full payment received (date of receipt of payment) Request granted | 19.02.2021 | Decision despatched | Fees paid | Renewal fee | 31.05.2021 | Renewal fee patent year 03 | 31.03.2022 | Renewal fee patent year 04 | 31.03.2023 | Renewal fee patent year 05 | 31.05.2024 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XYI]WO2016094456 (1GLOBE HEALTH INST LLC [US]) [X] 1-10,12-15 * paragraph [0082]; figure 1; claims 1-3,6-9 * [Y] 2,8 [I] 11; | [Y]WO2018027135 (UNUM THERAPEUTICS INC [US]) [Y] 2,8* claims 1,6 * | International search | [Y]US2004146889 (DOWDY STEVEN F [US], et al) [Y] 9, 15 * ; paragraphs [0013], [0026] *; | [Y]US2007207145 (OWENS S MICHAEL [US], et al) [Y] 8 * ; paragraph [0039] *; | [A]US2013078236 (MARY CAROLINE [FR], et al) [A] 14* ; paragraph [0039] *; | [Y]US2015139943 (CAMPANA DARIO [SG], et al) [Y] 1-9, 11-12, 15, 17-25 * ; abstract; paragraphs [0015], [0019], [0020], [0023], [0026], [0056], [0061], [0111], [0112], [0114], [0124], [0145], [0148] *; | [Y]WO2016178996 (UNIV CALIFORNIA [US]) [Y] 17, 19 * ; page 34, lines 1-2; page 27, lines 17-26 *; | [Y]WO2018022957 (TARVEDA THERAPEUTICS INC [US]) [Y] 1-9, 11-12, 15, 17-25 * ; [0056] *; | [Y]US2018057795 (CHILDS RICHARD W [US], et al) [Y] 12 * ; paragraph [0037] * | by applicant | WO2016094456 | WO2018027135 | - ALMAGRO et al., Front Immunol, (20170000), vol. 8, page 1751 | - SUBRAMANIAN et al., Cancer Management and Research, (20170000), vol. 9, pages 131 - 140 | - VAN DE DONK et al., Blood, (20180000), vol. 131, pages 13 - 29 | - K. CHIN et al., Annals of Oncology, (20170000), vol. 28, pages 1658 - 1666 | - HAMILTONRATH, Expert Opinion on Biological Therapy, (20170000), vol. 17, pages 515 - 523 | - SUZUKI et al., J Toxicol Pathol, (20150000), vol. 28, pages 133 - 139 | - HIDDEMANN et al., Blood, (20050000), vol. 106, pages 3725 - 32 | - POSTOW et al., J Clin Oncol, (20150000), vol. 33, pages 1974 - 1982 | - WANG et al., Front Immunol, (20150000), vol. 6, page 368 | - CARTRON et al., Blood, (20020000), vol. 99, pages 754 - 758 | - KIM et al., Blood, (20060000), vol. 108, pages 2720 - 2725 | - ZHANG et al., J Clin Oncol, (20070000), vol. 25, pages 3712 - 3718 | - MUSOLINO et al., J Clin Oncol, (20080000), vol. 26, pages 1789 - 1796 | - VEERAMANI et al., Blood, (20110000), vol. 118, pages 3347 - 3349 | - MELLOR et al., J Hematol Oncol, (20130000), vol. 6, page 1 | - GONNET et al., Science, (19920000), vol. 256, pages 1443 - 1445 | - ALTSCHUL et al., J. Mol. Biol., (19900000), vol. 215, pages 403 - 410 | - ALTSCHUL et al., Nucleic Acids Res., (19970000), vol. 25, pages 3389 - 402 | - REINEKE, Methods Mol Biol, (20040000), vol. 248, pages 443 - 463 | - TOMER, Protein Science, (20000000), vol. 9, pages 487 - 496 | - EHRING, Analytical Biochemistry, (19990000), vol. 267, no. 2, pages 252 - 259 | - ENGENSMITH, Anal. Chem., (20010000), vol. 73, pages 256A - 265A | - POWELL et al., "Compendium of excipients for parenteral formulations", J Pharm Sci Technol, (19980000), vol. 52, pages 238 - 311, XP009119027 | - MORDENTI et al., Pharmaceut. Res., (19910000), vol. 8, page 1351 | - WU et al., J. Biol. Chem., (19870000), vol. 262, pages 4429 - 4432 | - SEFTON, CRC Crit. Ref. Biomed. Eng., (19870000), vol. 14, page 201 | - GOODSON, Medical Applications of Controlled Release, (19840000), vol. 2, pages 115 - 138 | - LANGER, Science, (19900000), vol. 249, pages 1527 - 1533 | - PARDOLL, Nat Rev Cancer, (20120000), vol. 12, pages 252 - 264 | - TOPALIAN et al., Curr Opin Immunol, (20120000), vol. 24, pages 207 - 212 | - BOYERINAS et al., Cancer Immunol Res, (20150000), vol. 3, pages 1148 - 1157 | - HAYNES et al., N Engl J Med, (20120000), vol. 366, pages 1275 - 1286 | - PARSONS et al., Retrovirology, (20180000), vol. 15, page 58 | - MADHAVI et al., J Virol, (20170000), vol. 91, pages e00700 - 17 | - GAO et al., Human Vaccines Immunotherapeutics, (20170000), vol. 13, pages 1768 - 1773 | - COGHILL et al., Clin Cancer Res, (20160000), vol. 22, pages 3451 - 3457 | - MCVOY et al., Int J Mol Sci, (20180000), vol. 19, page 3982 | - SHEEHY et al., J Immunol Methods, (20010000), vol. 249, pages 99 - 110 | - CHEN et al., Clinical Immunology, (20020000), vol. 104, pages 58 - 66 | - AHMED et al., JCI Insight, (20180000), vol. 3, page e97805 | - ZHOU et al., Blood, (20120000), vol. 120, pages 4334 - 4342 |